Foyston, Gordon, & Payne’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Foyston, Gordon, & Payne's CME Position: Q3 2026 in Review
Foyston, Gordon, & Payne increased its CME Group (CME) stake by 25% in Q3 2026, buying an estimated $825K and bringing the position to 15,409 shares worth $4.04M. The position accounts for 0.81% of the portfolio, ranked #40.
Foyston, Gordon, & Payne first reported a position in CME in Q3 2020 and has held it in 25 quarters since. The position peaked at $4.83M in Q1 2024. 1,751 funds tracked by Wall St. Rank hold CME as of Q3 2026.
- Foyston, Gordon, & Payne held 15,409 shares of CME Group worth $4.04M as of Q3 2026.
- Foyston, Gordon, & Payne bought 3,128 CME Group shares in Q3 2026, an estimated $825K.
- CME Group made up 0.81% of Foyston, Gordon, & Payne's portfolio in Q3 2026, its #40 holding.
- Foyston, Gordon, & Payne first reported a position in CME Group in Q3 2020 and has held it in 25 quarters since.
- Foyston, Gordon, & Payne's CME Group position peaked at $4.83M in Q1 2024.
- 1,751 funds tracked by Wall St. Rank held CME Group as of Q3 2026.
Based on Foyston, Gordon, & Payne's 13F filing for Q3 2026, filed 2 Nov 2026.